These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24960539)

  • 1. Modest effects of lipid modifications on the structure of caveolin-3.
    Kim JH; Peng D; Schlebach JP; Hadziselimovic A; Sanders CR
    Biochemistry; 2014 Jul; 53(27):4320-2. PubMed ID: 24960539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pH-Mediated Topological Switch within the N-Terminal Domain of Human Caveolin-3.
    Kim JH; Schlebach JP; Lu Z; Peng D; Reasoner KC; Sanders CR
    Biophys J; 2016 Jun; 110(11):2475-2485. PubMed ID: 27276265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Interplays in the Flexible N-Terminus and Scaffolding Domain of Human Membrane Protein Caveolin 3.
    Park HJ; Jang J; Ryu KS; Lee J; Lee SH; Won HS; Kim EH; Seo MD; Kim JH
    Membranes (Basel); 2021 Jan; 11(2):. PubMed ID: 33499357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of synthetic peptides corresponding to the scaffolding domain of Caveolin-3 with model membranes.
    Sowmya BL; Jagannadham MV; Nagaraj R
    Biopolymers; 2006; 84(6):615-24. PubMed ID: 16948121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of Caveolin-1 into Artificial Lipid Membrane: Characterization by Transmission Electron Microscopy and Solid-State Nuclear Magnetic Resonance.
    Zhang Y; Zhang X; Kong W; Wang S
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CAV3 in long-QT syndrome: clinical and functional assessment of a caveolin-3/Kv11.1 double heterozygote versus caveolin-3 single heterozygote.
    Hedley PL; Kanters JK; Dembic M; Jespersen T; Skibsbye L; Aidt FH; Eschen O; Graff C; Behr ER; Schlamowitz S; Corfield V; McKenna WJ; Christiansen M
    Circ Cardiovasc Genet; 2013 Oct; 6(5):452-61. PubMed ID: 24021552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Role for Caveolin-3 in the Pathogenesis of Muscular Dystrophies.
    Pradhan BS; Prószyński TJ
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coiled-coil domain of MURC/cavin-4 is involved in membrane trafficking of caveolin-3 in cardiomyocytes.
    Naito D; Ogata T; Hamaoka T; Nakanishi N; Miyagawa K; Maruyama N; Kasahara T; Taniguchi T; Nishi M; Matoba S; Ueyama T
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(12):H2127-36. PubMed ID: 26497963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct molecular interaction of caveolin-3 with KCa1.1 channel in living HEK293 cell expression system.
    Suzuki Y; Yamamura H; Ohya S; Imaizumi Y
    Biochem Biophys Res Commun; 2013 Jan; 430(3):1169-74. PubMed ID: 23237801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inward Rectifier Potassium Channels (Kir2.x) and Caveolin-3 Domain-Specific Interaction: Implications for Purkinje Cell-Dependent Ventricular Arrhythmias.
    Vaidyanathan R; Van Ert H; Haq KT; Morotti S; Esch S; McCune EC; Grandi E; Eckhardt LL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005800. PubMed ID: 29326130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of excitation-contraction coupling and excitation coupled Ca(2+) entry in human myotubes carrying CAV3 mutations linked to rippling muscle.
    Ullrich ND; Fischer D; Kornblum C; Walter MC; Niggli E; Zorzato F; Treves S
    Hum Mutat; 2011 Mar; 32(3):309-17. PubMed ID: 21294223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular dissection of caveolin-1 membrane attachment and oligomerization. Two separate regions of the caveolin-1 C-terminal domain mediate membrane binding and oligomer/oligomer interactions in vivo.
    Schlegel A; Lisanti MP
    J Biol Chem; 2000 Jul; 275(28):21605-17. PubMed ID: 10801850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders.
    Gazzerro E; Bonetto A; Minetti C
    Handb Clin Neurol; 2011; 101():135-42. PubMed ID: 21496630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of a monogenetic insult, caveolin-3-V37L, that precipitated oligo-proteomic perturbations governing repolarization reserve.
    Ye D; Zhou W; Tester DJ; Ackerman MJ
    Int J Cardiol; 2020 Nov; 319():71-77. PubMed ID: 32387251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin proteins electrochemical oxidation and interaction with cholesterol.
    Fernandes IPG; Oliveira-Brett AM
    Bioelectrochemistry; 2020 Jun; 133():107451. PubMed ID: 32109845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophy-associated caveolin-3 mutations reveal that caveolae couple IL6/STAT3 signaling with mechanosensing in human muscle cells.
    Dewulf M; Köster DV; Sinha B; Viaris de Lesegno C; Chambon V; Bigot A; Bensalah M; Negroni E; Tardif N; Podkalicka J; Johannes L; Nassoy P; Butler-Browne G; Lamaze C; Blouin CM
    Nat Commun; 2019 Apr; 10(1):1974. PubMed ID: 31036801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-3 associates with and affects the function of hyperpolarization-activated cyclic nucleotide-gated channel 4.
    Ye B; Balijepalli RC; Foell JD; Kroboth S; Ye Q; Luo YH; Shi NQ
    Biochemistry; 2008 Nov; 47(47):12312-8. PubMed ID: 19238754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes.
    Li S; Song KS; Lisanti MP
    J Biol Chem; 1996 Jan; 271(1):568-73. PubMed ID: 8550621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The caveolin-3 P104L mutation in LGMD-1C patients inhibits non-insulin-stimulated glucose metabolism and growth but promotes myocyte proliferation.
    Shang L; Chen T; Xian J; Deng Y; Huang Y; Zhao Q; Liang G; Liang Z; Lian F; Wei H; Huang Q
    Cell Biol Int; 2019 Jun; 43(6):669-677. PubMed ID: 30958599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the molecular architecture of human caveolin-3 and interaction with the skeletal muscle ryanodine receptor.
    Whiteley G; Collins RF; Kitmitto A
    J Biol Chem; 2012 Nov; 287(48):40302-16. PubMed ID: 23071107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.